Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.36 |
| ▸ | TAS1R2 | Q8TE23 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14570826 | 0.94 | HPGD (0.35) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5995419 | 0.92 | KMT2A (0.37) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5997007 | 0.91 | KDM4E (0.36) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5995524 | 0.88 | KMT2A (0.33) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5995448 | 0.88 | PKM (0.38) | KMT2AMEN1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL5995387 | 0.87 | KMT2A (0.40) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5994972 | 0.87 | KMT2A (0.37) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5994494 | 0.86 | KMT2A (0.38) | KMT2AHPGDMEN1SMN1; SMN2LMNA | |
| SCHEMBL5994287 | 0.85 | HMGCR (0.35) | KMT2AHPGDMEN1CYP1A2CYP2C9 | |
| SCHEMBL5995481 | 0.85 | CYP3A4 (0.38) | KMT2AHPGDSMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586804-A2 | Photoradically and thermally radically curable composition | KANEKA CORPORATION (JP) | 2013-05-01 | — | — | EP | claimed |
| EP-0909288-B1 | PROCESS FOR CURING A POLYMERIZABLE COMPOSITION | CIBA SC HOLDING AG (CH) | 2007-06-27 | — | — | EP | claimed |
| US-6676999-B2 | HARDNESS OF THE CURED POLYURETHANE SURFACE COATING IS INCREASED BY MEANS OF IRRADIATION WITH UV LIGHT | CIBA SPECIALTY CHEMICALS CORP. | 2004-01-13 | — | — | US | claimed |
| US-20030203986-A1 | Process for curing a polymerizable composition | VALET ANDREAS (DE) | 2003-10-30 | — | — | US | claimed |
| US-6620857-B2 | Photopolymerization using photoinitiator; protective coatings | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-09-16 | — | — | US | claimed |
| US-6316519-B1 | CONTACTING MONOETHYLENICALLY UNSATURATED MONOMER WITH PHOTOINITIATOR; CONTACTING WITH ACTINIC RADIATION IN A PHOTOREACTOR, AND FORMING A LINEAR POLYMER OF CONTROLLED MOLECULAR WEIGHT | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-11-13 | — | — | US | claimed |
| US-20010034379-A1 | Process for curing a polymerizable composition | VALET ANDREAS (DE) | 2001-10-25 | — | — | US | claimed |
| EP-0909288-A1 | PROCESS FOR CURING A POLYMERIZABLE COMPOSITION | Ciba SC Holding AG (CH) | 1999-04-21 | — | — | EP | claimed |
| WO-1998000456-A1 | PROCESS FOR CURING A POLYMERIZABLE COMPOSITION | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1998-01-08 | — | — | WO | claimed |
| JP-5345790-A | — | — | None | — | — | JP | disclosed |
| WO-2026105802-A1 | RESIN COMPOSITION, DRY FILM, AND CURED PRODUCT | 太陽ホールディングス株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-12624140-B2 | Composition containing compound having polyoxyalkylene chain | RESONAC CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4711396-A1 | CURABLE COMPOSITION | Tokyo University of Science (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| WO-1998000456-A1 | PROCESS FOR CURING A POLYMERIZABLE COMPOSITION | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1998-01-08 | — | — | WO | disclosed |
| US-5616787-A | REACTING THE CORRESPONDING AROMATIC HYDROCARBON WITH CARBON DIOXIDE | CIBA-GEIGY CORPORATION (US) | 1997-04-01 | — | — | US | disclosed |
| US-5534559-A | UNSATURATED POLYESTERS | CIBA-GEIGY CORPORATION (US) | 1996-07-09 | — | — | US | disclosed |
| US-5472992-A | For printing inks, surface coatings, photoresists | CIBA-GEIGY CORPORATION (US) | 1995-12-05 | — | — | US | disclosed |
| US-5399770-A | Photoinitiator, preparation of printing plates, curing white paints | CIBA-GEIGY CORPORATION (US) | 1995-03-21 | — | — | US | disclosed |
| JP-H05345790-A | ALKYLBISACYLPHOSPHINE OXIDE | CIBA GEIGY AG | 1993-12-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | KMT2A 939/4885HPGD 3210/4885MEN1 2022/4885 |
| US-12624140-B2 | Composition containing compound having polyoxyalkylene chain | PIEZO1, HVCN1, TAF11 | KMT2A 3677/4885HPGD 387/4885MEN1 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.